Zitholele isayensi ngemuva kokwelashwa kwe-CAR T Cell eNdiya! Hlola ukuthi lokhu kwelashwa okuguquguqukayo kuwaguqula kanjani amaseli akho omzimba abe yizilwi zomdlavuza. Funda ibhulogi yethu manje ukuze ufunde kabanzi mayelana nalokhu kwelashwa okuyisimangaliso nokuthi kanjani ..
Wake wazibuza ukuthi ikhona yini indlela enamandla yokulwa nomdlavuza? Manje ake ucabange nje uma ngolunye usuku uthole umsebe wethemba ekulweni kwakho nomdlavuza, ukwelashwa okusebenzisa amandla amasosha omzimba wakho ukukhomba isifo somdlavuza.
Meyi 2023: I-Chimeric antigen receptor (CAR) I-T-cell therapy intuthuko entsha emkhakheni wokwelashwa komdlavuza ngamunye. Ama-T-cell esiguli ashintshwa ngokofuzo ngesikhathi senqubo yokukhiqiza ukuze aveze a..
Ngomhla zingama-23 kuNdasa 2023: Izindlela zokwelapha zomdlavuza ezitholakala ngaphambi kwesikhathi kanye nesigaba sokuqala somdlavuza ezithuthukiswa yi-Shanghai biotech Oricell bathole enye imali eyizigidi ezingama- $ 45, kumemezele inkampani ngoLwesibili. Kulandela umbukiso e-AS..
March 2023: CAR-T-cell therapy is a novel and effective cancer treatment modality that has revolutionized the treatment of cancer, particularly blood cancers. This therapy achieves a therapeutic effect or cures disease by repairi..
Feb 2024: Several new drugs and promising therapies, such as chimeric antigen receptor T-cell therapy, have ushered in a "renaissance" for lupus, according to a speaker at the symposium Basic and Clinical Immunology for the Busy ..
Ephreli 2022: Imvamisa, inqubo yokukhiqiza amaseli yokwelashwa kwe-CAR T-cell ithatha izinsuku eziyisishiyagalolunye kuya kweziyishumi nane; Nokho, abacwaningi eNyuvesi yasePennsylvania bakwazile ukwakha amaseli e-CAR T asebenzayo ane-anti-tumour ethuthukisiwe.
June 2016: Professor Huang He of Zhejiang University's First Affiliated Hospital presented the outcomes of 10 clinical cases, including CAR-T cell therapy for leukaemia treatment, at the 2016 Haematogenic Immunity Summit in Hangz..
Julayi 2021: I-Breyanzi (Lisocabtagene maraleucel; liso-cel), i-CD19-directed chimeric antigen receptor (CAR) T cell treatment eyakhiwe nguBristol Myers Squibb (BMS), ivunywe yi-US Food and Drug Administration (US.).
July 2021: In June 2014, KITE Biotechnology Company, with only 19 employees, was listed on NASDAQ in the United States, and it took 130 million US dollars in one day! Just two months later, Juno Biotechnology had less than 20 em..